Main Menu

Our Work

Swanston v. TAP Pharmaceutical Products

In Swanston v. TAP Pharmaceutical Products, provided expert testimony on issues of predominance and feasible damages methodologies on behalf of a joint defense group of leading pharmaceutical manufacturers opposing class certification. Analyzed reimbursements for both self-administered and physician-administered drugs made by patients covered by government-sponsored health insurance programs including Medicare, Medicaid, and TRICARE, patients covered by private health insurance programs, and patients without insurance. Submitted written report.

Jump to Page